. Was he looking for Ras-related proteins? No, he was looking for a snail ortholog of human chorionic gonadotropin hormonet The second member of the family to be identified, Rac, had no less a fortuitous beginning. The protein was purified and sequenced in 1989 as a Ras-related C3 transferase substrate (Didsbury et al., 1989) . Only later was it realized that the preparation was contaminated with Rho, the real C3 substrate. The third member of the family, Cdc42, was characterized in John Pringle's lab the following year (Johnson and Pringle, 1990) . It had a much more intellectually satisfying beginning, being the 42 nd cell division cycle mutant in Lee Hartwell's yeast screen back in the mid-1970s. So how did we get involved in this field? Let's start with Alan's story...
I was recruited as a molecular biologist to my first PI position at the Chester Beatty Laboratories in 1981 by the newly installed director, Robin Weiss, to work on human oncogenes. This was a great opportunity for me, but as a naive ex-postdoc who had just been working on the expression of recombinant interferon, I was a little worried how long the job would last once this cure for cancer reached the clinic. As it turned out, of course, interferon was not a magic bullet and this was an incredibly exciting time for a molecular biologist to move into cancer research. Numerous viral oncogenes had already been characterized, but recently developed assays coming out of the Weinberg and Cooper laboratories in Boston provided a new technique for isolating real human oncogenes. In a wonderful and close partnership that lasted 12 years, Chris Marshall and I went on to identify and clone a new human oncogene, N-ras (Hall et al., 1983) . Chris and I spent the rest of the 1980s trying *Correspondence: anne@ludwig.ucl.ac.uk (A.J.R.), alan.hall@ucLac. uk (A.H.) to identify a biochemical function for this regulatory GTP binding protein that is mutated in ~30% of human cancers. After some ups (Ras regulates PIP2 hydrolysis) and some downs (Ras does not regulate PIP2 hydrolysis), my infatuation with Ras began to fade a little. Chris's did not and his persistence was rewarded in 1992, when he and his PhD student Sally Leevers discovered a major function of Ras--to control the activation of the ERK MAP kinase pathway (Leevers and Marshall, 1992) .
It was in 1987 that I decided to resurrect three E. co/i strains containing some Ras-like, human cDNAs called Rho 6, 9, and 12, which Chris had requested from Pascal Madaule a year or so earlier. The plan was to generate a constitutively activated version of Rho12 (now called RhoA) by site-directed mutagenesis, make recombinant protein, and in collaboration with Hugh Paterson, a very talented cell biologist in Chris's lab, microinject this into fibroblasts to see if it "did anything interesting." The following year, and with the help of Connie van Oers (a Dutch undergraduate), Annette Self (a Research Assistant who is still with me today), and Michelle Garrett (a PhD student), the first microinjection experiment had been done and when I asked Hugh what had happened, he said not much--the cells just seemed to make some strange shapes. For someone who at that time was fixated on cell cycle progression and proliferation, this was a rather uninspiring result.
Concurrent with these goings on, several groups in the bacterial toxin field had observed that botulinum neurotoxin could ADP-ribosylate a 21 kDa protein and there was much excitement that it might be Ras. Working with Derek Knight in London, I was able to show that it was not, and in 1988 Takai's lab showed that it was, in fact, Rho. It soon became clear, however, that there was a problem and that the botulinum toxin was contaminated with another enzyme called C3 transferase. Klaus Aktories (then working in Giessen) and I went on to show that C3 transferase could directly ADPribosylate recombinant Rho protein (Aktories et al., 1989) . During this time, the labs of Michel Popoff, Patrice Bouquet, and the late Michael Gill had also been working on C3 transferase and had reported that cells treated with this enzyme lost most of their actin microfllaments (Chardin et al., 1989) . They concluded that Rho likely controls the actin cytoskeleton. Meanwhile, Hugh and I, along with Klaus, who had come (armed with purified C3) to do a short sabbatical in London, were in a position to publish our first results on the cellular effects of Rho in a JCB paper in 1990 (Paterson et al., 1990) . Using early passage Swiss 3T3 fibroblasts, a wonderfully "well-behaved" cell line that we obtained from Enrique Rozengurt and which we had used extensively to study Ras-induced cell cycle progression, we showed that the loss of actin filaments induced by C3 was due to inactivation of Rho function. When constitutively activated Rho was introduced into subconfluent cells, however, it induced unusual morphological changes that appeared to be due to cell contraction. Things were beginning to look a little more interesting, although we still had no real idea what was going on, other than that Rho did something to the actin cytoskeleton. However, Hugh's green fingers for cell biology led to a key experiment, which is shown in the final figure of that paper. He noticed that when Swiss 3T3 cells are allowed to become confluent and quiescent, much of their actin cytoskeleton disappears. When constitutively activated Rho is microinjected under these conditions, it induces the reappearance of a dense actin filament network. Along with Anne's arrival in the lab the same month that the JCB paper was published, this result set the scene for the work that culminated in the two 1992 Cell papers. Moving on to Anne's story... I had spent my PhD watching videos of Schwann cells responding to Ras (Ridley et al., 1988) , and then moved to Boston as a postdoc to sequence stretches of the Y chromosome. Realizing that I was not destined to become a genome analyst, I was lured by an advertisement in Nature to join Alan's laboratory and return to the Ras field. Armed with the latest Boston news from the grapevine that the neurofibromatosis gene product NF1 was a RasGAP, and given that neurofibromatosis is a disorder of Schwann cells, my first thoughts were to work on this in Alan's laboratory. However, after hearing about the effects of Rho on the actin cytoskeleton and spending a week reading about stress fibers and membrane ruffles (frankly, something neither of us knew anything about), I decided to tackle the Rho project and find out if it contributed to growth factor-induced changes to the actin cytoskeleton.
This involved learning to microinject. Fortunately Hugh Paterson was a patient teacher, and handled all the panic attacks induced by bubbling needles and sticky cells without batting an eyelid. He also taught me the elusive art of culturing Swiss 3T3 cells without allowing them to transform, something that was subsequently a major problem for everyone else who tried to follow up our results. Simultaneous to learning microinjection, I grabbed hold of every growth factor and stimulant I could find in the laboratory and added them to Swiss 3T3 cells to find something that emulated the effects of Rho in inducing stress fibers. It did not take long to find the best stimulus--fetal calf serum. However, it took much longer to isolate the serum component responsible. This involved learning the fine art of fast performance liquid chromatography (fplc), taught to me by Michelle Garrett, who had managed to purify the first RhoGAP . Little did I know that Chris Marshall thought Alan was crazy to even consider purifying anything from serum, while I spent endless hours in the cold room struggling with ailing fraction collectors. The fraction that contained the "stress fiber-inducing" substance also contained serum albumin, so I plunged into the library to unearth obscure papers on what might bind to this well-known, sticky protein. This revealed that several lipids bound, so to identify the "stress fiber" lipid, I used a combination of lipases to knock it out, then tested several purified lipids for their effects on stress fibers. Amazingly, both routes identified lysophosphatidic acid (LPA) as the major bioactive component of serum.
The crucial experiment that nailed Rho as the mediator of stress fiber induction was injecting C3 transferase into starved cells and adding back serum or LPA. Producing the photographs to illustrate this was a major hurdle. The C3 transferase and LPA had to be titrated and lots of time points tested to get the optimal response. After a morning of microinjection I would emerge bleary-eyed for a cup of tea, fix and stain the samples, and then take reels of photographs. We developed all our films and prints by hand in the darkroom--there was no photographic department and no digitized images in those days. Each figure represented hours in the darkroom playing with developing conditions to produce the end product.
While all this was going on, a new student in the laboratory, Dagmar Diekmann, had been set the task of cloning the Rac cDNA. Once she had produced constitutively active Rac in a mammalian expression vector, Hugh injected this into Swiss 3T3 cells and when he came back the next day, he noticed that it stimulated the accumulation of huge cytoplasmic vesicles, which turned out to be due to pinocytosis. Meanwhile, I had been testing the effects of PDGF and EGF on Swiss 3T3 cells and found that they induced membrane ruffling. (Later, we were politely informed of the difference between membrane ruffling and lamellipodia by actin afficionados, but at the time we were content to use the words interchangeably.) Ras had previously been reported by Jim Feramisco's laboratory to stimulate both membrane ruffling and pinocytosis, and so we realized that Rac could act similarly. Fortunately, Caroline Johnson had just constructed some bacterial GST-Rac vectors for her own project, so I purified constitutively active Rac protein and found that it stimulated lamellipodium extension. Interestingly, it also induced a few stress fibers as a later response-the link between Rac and Rho has been a source of controversy and discussion ever since.
Crucial to the completion of the Rac story was the construction of a dominant-negative (N17) protein. This was a shot in the dark, because at that time only N17Ras had been shown to act as a dominant-negative mutant, and it was not clear that Rac would behave similarly. N17Ras had been shown to have a reduced affinity for guanine nucleotides, so we determined the GTP-and GDP binding capacities of N17Rac and found that they were similar. But the important experiment was microinjecting N17Rac and showing that it inhibited PDGFand EGF-induced membrane ruffling. Again, the experiment sounds disarmingly simple, but it was difficult to purify N17Rac to a high enough concentration to inhibit ruffling, and my obsession with time courses and titrations was essential for finding the optimal conditions where inhibition was clear. When all the photographs were finally ready and labeled with letraset (who remembers letraset??), we realized there was way too much material for one paper and so divided it into Rho and Rac. This made a lot of sense, but was the only thing that the two Cell reviewers were really concerned about. Amazingly, the only extra experiment they asked for was to inject N17Ras protein and test whether it inhibited PDGF-induced membrane ruffling (to our surprise it did not). Fortunately, we convinced the editor that it was impossible to merge the papers--there were just too many figures and they were all essential. We also had the advantage that in those "pre-electronic" days, they could not be consigned to "supplementary material."
Despite the struggles with cold rooms, dark rooms, microinjection needles, and misbehaving Swiss 3T3 cells, these two years were enormously exciting and rewarding, The enthusiastic reception of the poster on our work at the Cold Spring Harbor Symposium in 1992 made all the effort worthwhile. It is true that we all had to spend a lot of time catching up on the actin cytoskeleton literature, but fortunately it was worth it and its relevance to so much of eukaryotic cell biology is now taken for granted.
During the same period, Rac was hitting the headlines for other reasons. Alan's laboratory discovered that Bcr was a GAP for Rac (Diekmann et al., 1991) and with Tony Segal, Arie Abo, and Edgar Pick showed that Rac activates the NADPH oxidase enzyme complex (Abo et al., 1991) . The link between Rac and the NADPH oxidase persisted as an oddity for another 3 or 4 years, before we realized that it was the tip of an iceberg of additional, nonactin functions controlled by these GTPases. A flurry of papers in 1995, showing that Rho, Rac, and Cdc42 regulated gene transcription (Coso et al., 1995; Hill et al., 1995; Minden et al., 1995) , started the ball rolling, while work initiated in yeast revealed the special and intimate relationship between Cdc42 and the establishment of cell polarity (reviewed in Pruyne and Bretscher, 2000) . One of the more interesting recent developments has been the emergence of Rho, Rac, and Cdc42 as key regulators of the microtubule cytoskeleton (reviewed in Wittmann and Waterman-Storer, 2001 ). We had looked for a possible link using Swiss 3T3 cells back in 1990, but the microtubule cytoskeleton does not simply disappear upon serum starvation and so we missed the more subtle, but no less important, effects of Rho and Rac on microtubule dynamics.
In conclusion, it has been a real privilege to have identified the two signal transduction pathways linking Rho and Rac to the actin cytoskeleton and to be part of the subsequent explosion of activity surrounding Rho GTPases. We could never have anticipated the response generated by our research and the huge impact that Rho GTPases would have on so many areas of biology. We were fortunate that circumstances, largely out of our control, converged at the right place and the right time, and we have snails, Swiss 3T3, and serum to thank for making such a wonderful Rac 'n' Rho story.
Introduction
The discovery that many human cancers contain oncogenic mutations in ras genes has stimulated much interest in the biological roles of ras and ms-related GTP-binding proteins (Bos, 1988; Downward, 1990; Hall, 1990) . Over 40 low molecular weight GTPases related to ras have now been identified, and they regulate a diverse range of cellular processes. Based on sequence homology, this superfamily can be divided into four subfamilies, ms, rho, rab, and arf, a grouping that also reflects similarities in function. There is now considerable evidence that the ras proteins themselves are essential components of receptor-mediated signal transduction pathways stimulating proliferation and differentiation (Hall, 1990; Downward, 1990) . In contrast, members of the rab and arf subfamilies are thought to regulate the transport of vesicles between intracellular compartments (Balch, 1990; Serafini et al., 1991; Kahn et al., 1991) .
The mammalian rho subfamily comprises the three highly related proteins rhoA, rhoB, and rhoC, two rac proteins, TC10, and two CDC42Hs proteins (also known as G25K) (Hall, 1990; Shinjo et al., 1990) . In addition, three related genes, CDC42Sc, RH01, and RH02, have been cloned from Saccharomyces cerevisiae (Johnson and Pringle, 1990 ). Characterization of the mammalian rho proteins has shown that they bind and hydrolyze GTP and that their intrinsic GTPase activity is stimulated by a GTPase-activating protein, rhoGAP, found in many cell types (Garrett et al., 1989 . Mutation of amino acid 14 from Gly to Val, equivalent to the Val-12 oncogenic mutation in ras, decreases the intrinsic GTPase activity of rho proteins and makes them unresponsive to rhoGAP (Garrett et al., 1989) . rhoGAP is also active on rac, whereas two proteins with sequence homology to rhoGAP, Bcr (the breakpoint cluster region gene product) and n-chimerin, act as GAPs for rac but not rho (Diekmann et al., 1991) . Three other proteins have been described that can interact with rho and rac in vitro, rhoGDI inhibits dissociation of GDP but not GTP from rho and rac, while smgGDS stimulates exchange of GDP for GTP on rho, rac, Ki-ras, and rap1 proteins (Fukumoto et al., 1990; Mizuno et al., 1991; Hiraoka et al., 1992) . Another activity named rhoGDS has been partially purified and stimulates nucleotide exchange on rho but not rap, and it is therefore probably distinct from smgGDS (Isomura et al., 1990) .
The first clues to a biological function for rho proteins came through the use of an exoenzyme produced by Clostridium botulinum, the C3 transferase, which ADP-ribosylates rho proteins on amino acid Asn-41 (Aktories et al., 1989; Sekine et al., 1989) . When C3 transferase is introduced into a vadety of cell types, they lose their actin stress fibers and round up (Rubin et al., 1988; Chardin et al., 1989; Paterson et al., 1990) . More direct evidence that rho acts on the actin cytoskeleton came from microinjecting cells with recombinant rho proteins or plasmids expressing rho cDNAs, rho was found to induce a rapid reorganization of actin into stress fibers in a variety of cell lines (Paterson et al., 1990) . These results suggest that rho proteins are involved in regulating the organization of polymerized actin.
A role for the actin cytoskeleton has been implicated in many cellular functions, including motility, chemotaxis, cell division, endocytosis, and secretion (Devreotes and Zigmond, 1988; Salmon, 1989; Bretscher, 1991) . Precise temporal and spatial control of actin filament organization is essential for these activities, but how this is achieved is not known. In fibroblasts, actin filaments exist principally in three types of structure, the cortical actin network, actin stress fibers, and cell surface protrusions including membrane ruffles and microspikes (Small, 1988) . Stress fibers emanate from distinct areas of the plasma membrane known as focal adhesions, where clusters of integrin receptors bind to extracellular matrix proteins such as flbronectin and collagen. A number of proteins are found associated with focal adhesions at the intracellular face of the plasma membrane, including vinculin, talin, tensin, and c~-actinin (Burridge et al., 1988) . Some of the interactions between these proteins, actin, and integrin receptors have been characterized, but little is known of the molecular mechanisms controlling focal adhesion and stress fiber formation (Burridge et al., 1988; Turner and Burridge, 1991) .
We have analyzed early changes in actin organization following the stimulation of quiescent serum-starved
The small GTP-binding proteins racl and rac2 are 92% homologous to each other and belong to the rho subfamily of ras-related proteins (Didsbury et al., 1989; Hall, 1990) . Like all other members of the ras superfamily, they bind and hydrolyze GTP, and several proteins have been identified that can regulate nucleotide exchange or stimulate their intrinsic GTPase activity in vitro (Diekmann et al., 1991; Hiraoka et al., 1992) . The racl gene is expressed in a variety of tissues and cell lines, whereas rac2 expression appears to be restricted to cells of hemopeietic lineages (Didabury et al., 1989; Shirsat et al., 1990; Moll et al., 1991) and is increased severalfold when the myeloid precursor cell line HL60 is induced to differentiate to a neutrophil-like morphology (Didsbury et al., 1989) .
Recently a specialized role for rac has been identified in phagocytic cells--activation of an NADPH oxidase to generate superoxide. This is part of a coordinated antibacterial defense mechanism, in which bacteria are phagocytosed and toxic superoxide is released into phagosomes (Morel et al., 1991) . Both racl and rac2 have been independently purified from phagocytes as activators of superoxide production in a reconstituted in vitro assay (Abo et al., 1991; Knaus et al., 1991) . Addition of purified recombinant racl bound to the nonhydrolyzable GTP analog GTP-~S, but not to GDP, stimulates the production of superoxide in this assay (Abe et al., 1991) . Two cytoplasmic proteins, p47 and p67, are also required to activate the membrane-bound NADPH oxidase, and their expression is restricted to myeloid cells (Morel et al., 1991) . racl, however, is expressed in other cell types and is therefore likely to have another function distinct from its role in phagocyte-specific superoxide generation. Other members of the rho subfamily appear to be involved in regulating actin organization. For example, the mammalian rho proteins have been shown to regulate the formation of actin stress fibers in fibroblasts (Paterson et aL, 1990; Ridley and Hall, 1992 , see accompanying paper in this issue of Cell). In addition, CDC42Sc, the Saccharomyces cerevisiae homolog of CDC42Hs, is involved in controlling cell polarity, which is linked to the spatial organization of polymedzed actin (Adams et al., 1990; Johnson and Pringle, 1990) . We have therefore studied the effects of racl on the actin cytoskeleton of fibroblasts.
Results

racl Stimulates Pinocytosis and Membrane Ruffling
To gain insight into the function of rac, we microinjected a euka~otic expression vector encoding activated racl with a mutation of amino acid 12 from Gly ((3) to Val (V) (pEXV-V12rac1, equivalent to the V12 oncogenic mutation in ras) into the nuclei of subconfluent Rat2 fibroblasts. As with ras, this mutation decreases the intrinsic GTPase activity of racl and makes it unresponsive to GTPaseactivating proteins (GAPs) (Diekmann et al., 1991) . To identify which cells were expressing the construct, the protein was tagged with a myc epitope recognized by the monoclonal antibody 9E10 at its N-terminus (Evan et al., 1985) . The cells were observed by cinemicroscopy to determine whether racl expression led to a distinct phenotype. Six hours following injection vesicles began to appear, increasing in number and size until they filled the whole cytoplasm (Figure 1 b) . V12rac1 was found by immunofluorescence to be localized to the surface of the vesicles and also to the plasma membrane (Figure la) . Most microinjected cells eventually rounded up and detached from the substratum. As a control, cells were injected with a vector encoding a mutant racl protein with amino acid 35 changed from Thr (T) to Ala (A) (pEXV-V12A35rac1). This amino acid is conserved in all members of the ras superfamily, and has been shown to be essential for ms function (Bourne et al., 1991) . No vesicle formation was observed in cells injected with pEXV-V12A35rac1.
The appearance of large vesicles in fibroblasts is most likely due either to an increase in uptake of plasma membrane vesicles by a pinocytotic mechanism or to the abnormal accumulation of an intracellular trafficking compartment. To distinguish between these two possibilities, uptake of culture medium containing the fluorescent dye
